Price
No data yet.
Social Signal Score
Revenue
$0.00Company Profile
- CEO
- Vinod Menon
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7
- Beta
- 0.15
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -2.11
Financials
Net Income
$-20.17MEBITDA
$-16.93MFree Cash Flow
$-6.18MEPS (diluted)
$-11.77Shares Outstanding (diluted)
1.63M+1186.4%Operating Expenses
$6.28MCash & Debt
$278.4KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-6.00M | $-5.50 |
| 2024 | $0.00 | $-1.39M | $-12.00 |
| 2023 | $0.00 | $-777.7K | $-6.75 |
| 2022 | $0.00 | $-668.7K | $-5.80 |
| 2021 | $0.00 | $-1.03M | $-8.90 |
Valuation
APUShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
110Social Signal Score
Mentions (2)
- Newsbenzinga.com·5h ago·Positive
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening? Apimeds Pharmaceuticals US Inc. (NYSE:APUS) shares are surging Thursday morning after its wholly owned subsidiary, MindWave Innovations Inc., announced a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to build and operate AQUAEChain.
View source ↗ - Newsglobenewswire.com·8h ago·Negative
MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits MindWave will supply and operate the technology, while AQUAE leads the ALCI Credits methodology, brand and market development MindWave will supply and operate the technology, while AQUAE leads the ALCI Credits methodology, brand and market development
View source ↗
Insider trading
Open-market buys and sells by APUS officers and directors.
- Bought
- $2.1m
- Sold
- —
4 trades
0 trades
- Kim Christopherbought
- Kim Christopherbought
- Koo Jakapbought
- Inscobee Inc.bought
41 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in APUS.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.